Since the first demonstration of GLP-1 receptor cloning and functional expression 20 years ago, enormous research efforts have been focused on developing GLP-1 receptor agonists to treat diabetes, resulting in first-in-human proof-of-concept studies in the early 2000s. Here, GLP1R is linked to diabetes mellitus.